Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

The status of fasting triglycerides as a risk factor for coronary artery disease (CAD) has been considered weak because in multivariate analyses, triglycerides tend to be eliminated by high density lipoprotein (HDL) cholesterol. To further evaluate the role of triglycerides in CAD, we employed postprandial lipemia as a more informative means of characterizing triglyceride metabolism. In 61 male subjects with severe CAD and 40 control subjects without CAD as verified by angiography, we measured cholesterol; triglycerides; HDL cholesterol; HDL2 cholesterol; and apolipoproteins A-I, A-II, and B in fasting plasma and triglycerides before and 2, 4, 6, and 8 hours after a standardized test meal. Both the maximal triglyceride increase and the magnitude of postprandial lipemia (area under the triglyceride curve over 8 hours after the meal) were higher in cases than in control subjects. Single postprandial triglyceride levels 6 and 8 hours after the meal were highly discriminatory (p < 0.001), and by logistic-regression analysis displayed an accuracy of 68% in predicting the presence or absence of CAD. In this respect, accuracy was higher than that of HDL2 cholesterol (64%) and equal to that of apolipoprotein B (68%), the most discriminatory fasting parameter. Multivariate logistic-regression analysis was performed to reduce the number of risk factors to those that were statistically independent. This statistical procedure selected postprandial but not fasting triglycerides into the most accurate multivariate model, which also contained the accepted risk factors HDL2 cholesterol, apolipoprotein B, and age. This model classified 82% of subjects correctly. We conclude that triglycerides are independent predictors of CAD in multivariate analyses including HDL cholesterol, provided that a challenge test of triglyceride metabolism such as postprandial lipemia is used. The study suggests that the metabolism of triglycerides is a critical determinant of cholesterol metabolic routing. The findings support the concept that the negative association between HDL cholesterol levels and CAD actually originates in part from a positive relation between CAD and plasma triglycerides, as ascertained in the postprandial state.

[1]  W. Sluiter,et al.  Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. , 1989, Arteriosclerosis.

[2]  A. Tall,et al.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.

[3]  A. Gotto,et al.  Effects of cyclosporine therapy on plasma lipoprotein levels. , 1989, JAMA.

[4]  R. Havel,et al.  Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. , 1985, Journal of lipid research.

[5]  R. Havel,et al.  Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. , 1973, Biochemistry.

[6]  C. Packard,et al.  Metabolism of apolipoproteins A‐I and A‐ll and its influence on the high density lipoprotein subfraction distribution in males and females , 1978, European journal of clinical investigation.

[7]  A. Hofman,et al.  Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[9]  A. Gotto,et al.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. , 1987, The Journal of clinical investigation.

[10]  A. Tall,et al.  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins , 1989, Nature.

[11]  G. Heiss,et al.  Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. , 1980, Journal of chronic diseases.

[12]  P. Rigo,et al.  Value, sensitivity and specificity of stroke volume ratio in routine equilibrium gated scintigraphy. , 1987, European heart journal.

[13]  J. Hupp.  Lowering Blood Cholesterol to Prevent Heart Disease , 1985, International Journal of Technology Assessment in Health Care.

[14]  G. Utermann,et al.  Apolipoprotein E phenotyping from serum by Western blotting , 1986 .

[15]  J. Patsch,et al.  Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients , 1989, European journal of clinical investigation.

[16]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .

[17]  P. Barter,et al.  Transfers and exchanges of esterified cholesterol between plasma lipoproteins. , 1982, The Biochemical journal.

[18]  D. Beischer,et al.  CHANGES IN SERUM LIPOPROTEINS AFTER A LARGE FAT MEAL IN NORMAL INDIVIDUALS AND IN PATIENTS WITH ISCHEMIC HEART DISEASE. , 1963, American heart journal.

[19]  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. , 1987, European heart journal.

[20]  W. Gruber,et al.  Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[21]  J. Patsch,et al.  Plasma lipoprotein changes resulting from immunologically blocked lipolysis. , 1981, Journal of lipid research.

[22]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[23]  D. B. Zilversmit,et al.  Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. , 1983, The Journal of biological chemistry.

[24]  B. Bronte-Stewart,et al.  ALIMENTARY LIPÆMIA AND HEPARIN CLEARING IN ISCHÆMIC HEART-DISEASE , 1959 .

[25]  A. Gotto,et al.  Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Kaplan,et al.  Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. , 1991, The Journal of clinical investigation.

[27]  H. Mabuchi,et al.  Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. , 1985, Atherosclerosis.

[28]  L. Carlson,et al.  Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. , 2009 .

[29]  J. Mitchell,et al.  Alimentary lipaemia and haparin clearing in ischaemic heart-disease. , 1959, Lancet.

[30]  C. Fielding,et al.  Effects of postprandial lipemia on plasma cholesterol metabolism. , 1985, The Journal of clinical investigation.

[31]  C. Fielding,et al.  Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content. , 1981, The Journal of biological chemistry.

[32]  J. E. Chapman,et al.  Fat tolerance in subjects with atherosclerosis: heparin effects upon lipemia, lipoproteins, and gamma globulin. , 1954, American heart journal.

[33]  C. Packard,et al.  Postprandial lipemia, fenofibrate and coronary artery disease. , 1990, Atherosclerosis.

[34]  P. Nestel,et al.  Catabolism of very low density lipoprotein B apoprotein in man. , 1978, The Journal of clinical investigation.

[35]  R. Bawol,et al.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.

[36]  D H Blankenhorn,et al.  Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. , 1990, Circulation.

[37]  M. Weintraub,et al.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. , 1987, The Journal of clinical investigation.

[38]  H. Brewer,et al.  Human chylomicron apolipoprotein metabolism. , 1978, Biochemical and biophysical research communications.

[39]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[40]  Judkins Mp.  Percutaneous transfemoral selective coronary arteriography. , 1968 .

[41]  J. Doyle,et al.  Postprandial lipemia in health and in ischemic heart disease ; a comparison of three indexes of fat absorption and removal and their modification by systemic heparin administration. , 1961 .

[42]  K. Vranizan,et al.  The effects of running mileage and duration on plasma lipoprotein levels. , 1982, JAMA.

[43]  S. Eisenberg,et al.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. , 1978, Journal of lipid research.

[44]  R. Havel.  Role of triglyceride-rich lipoproteins in progression of atherosclerosis. , 1990, Circulation.

[45]  H. Brewer,et al.  Human apolipoprotein A-I and A-II metabolism. , 1982, Journal of lipid research.

[46]  M. Austin.  Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[47]  A. Gotto,et al.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. , 1984, The Journal of clinical investigation.

[48]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[49]  M. Taskinen,et al.  Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism. , 1987, American heart journal.

[50]  M. P. Judkins,et al.  Selective Coronary Arteriography , 1967 .

[51]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[52]  M. Denborough.  ALIMENTARY LIPAEMIA IN ISCHAEMIC HEART DISEASE. , 1963, Clinical science.

[53]  F. Berr,et al.  Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. , 1984, Journal of lipid research.

[54]  G. Schonfeld.  Blood lipids and lipoproteins; quantitation, composition and metabolism , 1973 .

[55]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[56]  J. Breslow,et al.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. , 1990, Science.

[57]  D. W. Barritt.  Alimentary Lipaemia in Men with Coronary Artery Disease and in Controls , 1956, British medical journal.

[58]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[59]  J. Brunzell.  Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome , 1989 .

[60]  A. Tall,et al.  Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. , 1986, The Journal of clinical investigation.

[61]  D. B. Zilversmit.  Atherogenesis: a postprandial phenomenon. , 1979, Circulation.

[62]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[63]  A. Gotto,et al.  A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. , 1989, Clinical chemistry.

[64]  A. Tall.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. , 1990, The Journal of clinical investigation.

[65]  J. Albers,et al.  Isolation and Characterization of Human Plasma Lipid Transfer Proteins , 1984, Arteriosclerosis.

[66]  D. Ballantyne,et al.  High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. , 1982, Metabolism: clinical and experimental.

[67]  J. Breslow,et al.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. , 1989, The Journal of biological chemistry.

[68]  S. Bellet,et al.  Use of I131-labelled fat in the study of lipid handling in patients with coronary artery disease☆ , 1959 .

[69]  R. A. Johnson,et al.  Prognostic value of a coronary artery jeopardy score. , 1985, Journal of the American College of Cardiology.

[70]  J. K. Dunn,et al.  Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: primacy of baseline ejection fraction. , 1991, Journal of the American College of Cardiology.

[71]  P. Nestel.  RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS. , 1964, The Journal of clinical investigation.

[72]  A. Hamsten,et al.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.